J&J | Прибыль До Налогообложения



Pre Tax Profit Изменить Дата
AbbVie USD 4.81B 1.54B 2024-12
Abbott USD 1.78B 252M 2025-03
Amgen USD 3.38B 111M 2024-12
AstraZeneca USD 3.4B 1.74B 2025-03
Baxter International USD -289000000 594M 2024-12
Bayer EUR 1.83B 2.31B 2025-03
Becton, Dickinson and Co. USD 306M 1.01B 2024-12
Biogen USD 572.2M 118.5M 2024-12
Boston Scientific USD 941M 302M 2025-06
Bristol-Myers Squibb USD 2.97B 1.29B 2025-03
CONMED USD 43.64M 3.69M 2024-12
Cooper Companies USD 144.5M 8.8M 2025-04
Dexcom USD 231.9M 5.1M 2024-12
Edwards Lifesciences USD 400.2M 33.7M 2025-06
Eli Lilly USD 3.46B 2.08B 2025-03
Gilead Sciences USD 2.96B 112M 2024-12
GlaxoSmithKline GBP 2.11B 1.55B 2025-03
Globus Medical USD 103.67M 17.05M 2025-03
Hologic USD 296.4M 600K 2024-12
Indivior 59M 29M 2025-03
Insulet USD 48.1M 63.2M 2025-03
Integra LifeSciences USD -18237000 98.27M 2024-12
Intuitive Surgical USD 832.1M 163.6M 2025-06
J&J USD 13.63B 8.21B 2025-03
Medtronic USD 1.54B 455M 2025-01
Merck USD 5.9B 683M 2025-03
Merit Medical Systems USD 37.96M 112.04M 2025-03
Novartis USD 4.53B 124M 2025-06
Pfizer USD 4.44B 2.36B 2024-12
Regeneron Pharmaceuticals USD 905M 53.1M 2025-03
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi EUR 2.16B 20M 2025-03
Stryker USD 1.64B 376M 2024-12
Tandem Diabetes Care USD -122089000 30.22M 2025-03
Teva Pharmaceutical Industries USD 294M 605M 2025-03
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12
Zimmer Biomet Holdings USD 289M 104.4M 2024-12
Zoetis USD 773M 144M 2024-12


J&J Прибыль До Налогообложения - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Jul 2025.